HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raul G Nogueira Selected Research

Thrombectomy

12/2022Quantification of clot spatial heterogeneity and its impact on thrombectomy.
11/2022International controlled study of revascularization and outcomes following COVID-positive mechanical thrombectomy.
9/2022Addition of intracranial aspiration to balloon guide catheter does not improve outcomes in large vessel occlusion anterior circulation stent retriever based thrombectomy for acute stroke.
8/2022Embotrap Extraction & Clot Evaluation & Lesion Evaluation for NeuroThrombectomy (EXCELLENT) Registry design and methods.
6/2022Device size selection can enhance Y-stentrieving efficacy and safety as a rescue strategy in stroke thrombectomy.
6/2022Mechanical thrombectomy with a novel device: initial clinical experience with the ANA thrombectomy device.
5/2022The Prognostic Value of Quantitative EEG in Patients Undergoing Mechanical Thrombectomy for Acute Ischemic Stroke.
4/2022Histological composition of retrieved emboli in acute ischemic stroke is independent of pre-thrombectomy alteplase use.
4/2022Histological evaluation of acute ischemic stroke thrombi may indicate the occurrence of vessel wall injury during mechanical thrombectomy.
4/2022Endovascular therapy with or without intravenous thrombolysis in acute stroke with tandem occlusion.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raul G Nogueira Research Topics

Disease

182Stroke (Strokes)
12/2022 - 04/2008
123Ischemic Stroke
12/2022 - 10/2004
29Infarction (Infarctions)
09/2022 - 10/2008
14Intracranial Hemorrhages (Intracranial Hemorrhage)
06/2022 - 02/2009
13Thrombosis (Thrombus)
09/2022 - 04/2008
13Cerebral Infarction
01/2022 - 01/2007
10COVID-19
11/2022 - 01/2020
10Hemorrhage
10/2021 - 10/2004
8Atrial Fibrillation
07/2021 - 10/2010
7Cerebral Hemorrhage
11/2021 - 10/2010
7Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2021 - 04/2008
7Brain Ischemia (Cerebral Ischemia)
10/2021 - 10/2008
7Hypertension (High Blood Pressure)
08/2021 - 10/2010
6Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
09/2020 - 07/2005
4Aneurysm (Aneurysms)
10/2022 - 12/2010
4Embolism (Embolus)
12/2021 - 12/2009
3Thrombocytopenia (Thrombopenia)
01/2022 - 10/2013
3Aphasia (Dysphasia)
12/2021 - 01/2017
3Heart Failure
11/2021 - 10/2010
3Ischemia
10/2021 - 04/2020
3Thromboembolism
07/2021 - 10/2013
3Pathologic Constriction (Stenosis)
01/2021 - 05/2013
3Hematoma
05/2016 - 10/2013
3Diabetes Mellitus
03/2016 - 07/2005
3Intracranial Aneurysm (Cerebral Aneurysm)
11/2013 - 11/2005
3Intracranial Vasospasm
10/2013 - 01/2007
2Pneumonia (Pneumonitis)
11/2021 - 03/2014
2Atherosclerosis
10/2021 - 01/2020
2Neurologic Manifestations (Neurological Manifestations)
11/2020 - 07/2019
2Hyperglycemia
11/2018 - 07/2005
2Rupture
01/2011 - 12/2010
1Ruptured Aneurysm
10/2022
1Vascular Remodeling
01/2021
1Infections
09/2020
1Dyslipidemias (Dyslipidemia)
01/2020
1Overweight
01/2020
1Transient Ischemic Attack
03/2019
1Parotitis (Parotiditis)
02/2018
1Fistula
03/2017
1Siderosis
01/2016
1Respiratory Insufficiency (Respiratory Failure)
05/2014

Drug/Important Bio-Agent (IBA)

36Tissue Plasminogen Activator (Alteplase)FDA Link
04/2022 - 10/2004
21Cytidine Triphosphate (CTP)IBA
03/2022 - 08/2009
13Glucose (Dextrose)FDA LinkGeneric
11/2021 - 11/2011
7Blood Glucose (Blood Sugar)IBA
09/2022 - 07/2005
5Heparin (Liquaemin)FDA LinkGeneric
01/2020 - 10/2013
4FibrinIBA
12/2021 - 11/2019
3Biomarkers (Surrogate Marker)IBA
04/2020 - 05/2012
2Phenobarbital (Luminal)FDA Link
01/2021 - 05/2013
2Neuroprotective AgentsIBA
01/2020 - 03/2014
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2020 - 12/2011
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2019 - 10/2008
2Indicators and Reagents (Reagents)IBA
01/2019 - 12/2018
1Tirofiban (Aggrastat)FDA Link
12/2022
1SilkFDA Link
10/2022
1von Willebrand FactorIBA
05/2022
1VaccinesIBA
01/2022
1Hemoglobins (Hemoglobin)IBA
11/2021
1hemoglobin ASIBA
11/2021
1LipidsIBA
08/2021
1oxidized low density lipoproteinIBA
08/2021
1Therapeutic UsesIBA
01/2021
1cyclo(Arg-Pro) (CI 4)IBA
01/2021
1fostriecinIBA
01/2021
1boldenone undecylenate (Equipoise)IBA
06/2020
1SolutionsIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1LDL CholesterolIBA
10/2018
1Anesthetics (Anesthetic Agents)IBA
01/2018
12- amino- 1- (4- chlorophenyl)- 3- fluoropropaneIBA
01/2018
1Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2018
1CreatinineIBA
12/2017
1ethyleneIBA
03/2017
1EnbucrilateIBA
03/2017
1AnticoagulantsIBA
01/2017
1PH.3IBA
04/2016
1HemosiderinIBA
01/2016
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
05/2014

Therapy/Procedure

139Thrombectomy
12/2022 - 12/2009
110Therapeutics
12/2022 - 04/2008
50Stents
09/2022 - 04/2009
19Catheters
09/2022 - 01/2011
17Punctures
01/2022 - 03/2013
8General Anesthesia
12/2021 - 06/2010
6Time-to-Treatment
03/2022 - 02/2009
5Length of Stay
11/2022 - 07/2005
5Endovascular Procedures
10/2022 - 01/2015
4Anesthesia
12/2021 - 05/2014
4Aftercare (After-Treatment)
01/2019 - 04/2009
3Treatment Delay
02/2022 - 09/2016
3Secondary Prevention
11/2021 - 01/2011
3Thrombolytic Therapy
09/2012 - 08/2009
2Critical Care (Surgical Intensive Care)
09/2020 - 04/2013
2Conscious Sedation
12/2017 - 06/2010
1Hospice Care (Care, Bereavement)
02/2022
1Personal Protective Equipment
09/2020
1Carotid Endarterectomy
12/2019
1Analgesia
01/2019
1Embolectomy
01/2017
1Contraindications
12/2015